Lineage Cell Therapeutics, Inc. - LCTX

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 15
Latest filed: Mar 12, 2026
Form Count
4 8
8-K 6
SCHEDULE 13D/A 1

Latest files

Filed Form Report period Accession SEC
Mar 12, 2026 4 Mar 12, 2026 0001193125-26-104106 View
Mar 11, 2026 8-K Mar 11, 2026 0001193125-26-101167 View
Mar 06, 2026 4 Mar 05, 2026 0001193125-26-097181 View
Mar 06, 2026 4 Mar 05, 2026 0001193125-26-097184 View
Mar 06, 2026 4 Mar 05, 2026 0001193125-26-097185 View
Mar 05, 2026 8-K Mar 05, 2026 0001193125-26-093948 View
Feb 13, 2026 4 Feb 11, 2026 0001193125-26-052020 View
Feb 13, 2026 4 Feb 11, 2026 0001193125-26-052021 View
Dec 19, 2025 4 Dec 19, 2025 0001193125-25-327279 View
Dec 19, 2025 4 Dec 19, 2025 0001193125-25-327280 View
Nov 28, 2025 8-K Nov 28, 2025 0001193125-25-302552 View
Nov 24, 2025 8-K Nov 20, 2025 0001193125-25-291979 View
Nov 14, 2025 SCHEDULE 13D/A 0000919574-25-007051 View
Nov 12, 2025 8-K Nov 12, 2025 0001193125-25-276249 View
Nov 06, 2025 8-K Nov 06, 2025 0001193125-25-269534 View